Literature DB >> 24879423

Defining the radiobiology of prostate cancer progression: An important question in translational prostate cancer research.

Srinivas Vourganti1, Jeffrey Donaldson2, Linda Johnson3, Baris Turkbey3, Gennady Bratslavsky2, Leszek Kotula4.   

Abstract

Prostate cancer is one of the most common malignancies affecting men worldwide. High mortality rates from advanced and metastatic prostate cancer in the United States are contrasted by a relatively indolent course in the majority of cases. This gives hope for finding methods that could direct personalized diagnostic, preventative, and treatment approaches to patients with prostate cancer. Recent advances in multiparametric magnetic resonance imaging (MP-MRI) offer a noninvasive diagnostic intervention which allows correlation of prostate tumor image characteristics with underlying biologic evidence of tumor progression. The power of MP-MRI includes examination of both local invasion and nodal disease and might overcome the challenges of analyzing the multifocal nature of prostate cancer. Future directions include a careful analysis of the genomic signature of individual prostatic lesions utilizing image-guided biopsies. This review examines the diagnostic potential of MRI in prostate cancer.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Prostate cancer; image-guided biopsy; lymph node imaging; magnetic resonance imaging; radiobiology

Year:  2014        PMID: 24879423      PMCID: PMC4478242          DOI: 10.1177/1535370214536669

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  71 in total

1.  Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.

Authors:  Byung Kwan Park; Bohyun Kim; Chan Kyo Kim; Hyun Moo Lee; Ghee Young Kwon
Journal:  J Comput Assist Tomogr       Date:  2007 Jul-Aug       Impact factor: 1.826

2.  Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer.

Authors:  V Panebianco; A Sciarra; A Marcantonio; V Forte; T Biondi; A Laghi; C Catalano
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-08       Impact factor: 2.346

3.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.

Authors:  Hari Trivedi; Baris Turkbey; Ardeshir R Rastinehad; Compton J Benjamin; Marcelino Bernardo; Thomas Pohida; Vijay Shah; Maria J Merino; Bradford J Wood; W Marston Linehan; Aradhana M Venkatesan; Peter L Choyke; Peter A Pinto
Journal:  Urology       Date:  2012-01       Impact factor: 2.649

4.  Detection of lymph node metastases by contrast-enhanced MRI in an experimental model.

Authors:  Patrick Wunderbaldinger; Lee Josephson; Christoph Bremer; Anna Moore; Ralph Weissleder
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

5.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

Review 6.  Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Authors:  Jennifer K Logan; Soroush Rais-Bahrami; Baris Turkbey; Andrew Gomella; Hayet Amalou; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

Review 7.  Role of high-field MR in studies of localized prostate cancer.

Authors:  Miriam W Lagemaat; Tom W J Scheenen
Journal:  NMR Biomed       Date:  2013-05-24       Impact factor: 4.044

8.  Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.

Authors:  Gabriel P Haas; Nicolas Barry Delongchamps; Richard F Jones; Vishal Chandan; Angel M Serio; Andrew J Vickers; Mary Jumbelic; Gregory Threatte; Rus Korets; Hans Lilja; Gustavo de la Roza
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

9.  Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.

Authors:  Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

10.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.